Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Jackson, P. E.
Right arrow Articles by Povey, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jackson, P. E.
Right arrow Articles by Povey, A. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 18, 1299-1302, Copyright © 1997 by Oxford University Press

ARTICLES

Low O6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-->AT transition in the K-ras oncogene

PE Jackson, CN Hall, PJ O'Connor, DP Cooper, GP Margison and AC Povey
Cancer Research Campaign Department of Carcinogenesis, Paterson Institute for Cancer Research, Manchester, UK.

O6-alkylguanine DNA-alkyltransferase (ATase) provides protection against the toxic, mutagenic and carcinogenic effects of alkylating agents, principally by removing the promutagenic lesion O6-alkylguanine from DNA. Differences in ATase activity in human tissue may thus determine mutational susceptibility. As GC-->AT transitions, which can be induced by O6-alkylguanine in DNA, are commonly observed in the K- ras oncogene of alkylating agent induced animal tumours and in human colorectal tumours, we have examined whether differences in ATase activity may affect the risk of K-ras mutations in humans with colorectal tumours. NTase activity in normal tissue from individuals with a K-ras mutation in colorectal tissue and more specifically a GC-- >AT transition (but not a transversion mutation) was significantly lower than that in individuals without a mutation (P < 0.01). Thus, individuals with low ATase activity in normal tissue (i.e. below the median) were at increased risk of having a transition (OR 10.1; 95% CI 1.9-99.0), but not a transversion mutation (OR 1.7; 95% CI 0.3-12.2). There were no significant differences in tumour ATase activity in individuals with or without a mutation. These results suggest that ATase can protect colorectal tissue against the mutagenic effects of alkylating agents and furthermore, that alkylating agent exposure plays a role in the aetiology of colorectal tumours containing a GC-->AT transition in the K-ras oncogene.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CarcinogenesisHome page
H. A. Billson, K. L. Harrison, N. P. Lees, C. N. Hall, G. P. Margison, and A. C. Povey
Dietary variables associated with DNA N7-methylguanine levels and O6-alkylguanine DNA-alkyltransferase activity in human colorectal mucosa
Carcinogenesis, April 1, 2009; 30(4): 615 - 620.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
N P Lees, K L Harrison, C N Hall, G P Margison, and A C Povey
Human colorectal mucosal O6-alkylguanine DNA-alkyltransferase activity and DNA-N7-methylguanine levels in colorectal adenoma cases and matched referents
Gut, March 1, 2007; 56(3): 380 - 384.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Halford, A Rowan, E Sawyer, I Talbot, and I Tomlinson
O6-methylguanine methyltransferase in colorectal cancers: detection of mutations, loss of expression, and weak association with G:C>A:T transitions
Gut, June 1, 2005; 54(6): 797 - 802.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
N. P. Lees, K. L. Harrison, C. N. Hall, G. P. Margison, and A. C. Povey
Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents
Carcinogenesis, July 1, 2004; 25(7): 1243 - 1247.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
E. T. Donnelly, H. Bardwell, G. A. Thomas, E. D. Williams, M. Hoper, P. Crowe, W. G. McCluggage, M. Stevenson, D. H. Phillips, A. Hewer, et al.
Modulation of N-methyl-N-nitrosourea-induced crypt restricted metallothionein immunopositivity in mouse colon by a non-genotoxic diet-related chemical
Carcinogenesis, May 1, 2004; 25(5): 847 - 855.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
T. Ueki, A. W. Hsing, Y.-T. Gao, B.-S. Wang, M.-C. Shen, J. Cheng, J. Deng, J. F. Fraumeni Jr., and A. Rashid
Alterations of p16 and Prognosis in Biliary Tract Cancers from a Population-Based Study in China
Clin. Cancer Res., March 1, 2004; 10(5): 1717 - 1725.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
P. E. Jackson, P. J. O'Connor, D. P. Cooper, G. P. Margison, and A. C. Povey
Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine
Carcinogenesis, March 1, 2003; 24(3): 527 - 533.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
A. C. Povey, A. F. Badawi, D. P. Cooper, C. N. Hall, K. L. Harrison, P. E. Jackson, N. P. Lees, P. J. O'Connor, and G. P. Margison
DNA Alkylation and Repair in the Large Bowel: Animal and Human Studies
J. Nutr., November 1, 2002; 132(11): 3518S - 3521.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
C. Colussi, S. Fiumicino, A. Giuliani, S. Rosini, P. Musiani, C. Macri, C. S. Potten, M. Crescenzi, and M. Bignami
1,2-Dimethylhydrazine-Induced Colon Carcinoma and Lymphoma in msh2-/- Mice
J Natl Cancer Inst, October 17, 2001; 93(20): 1534 - 1540.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
A C Povey, C N Hall, A F Badawi, D P Cooper, and P J O'Connor
Elevated levels of the pro-carcinogenic adduct, O6-methylguanine, in normal DNA from the cancer prone regions of the large bowel
Gut, September 1, 2000; 47(3): 362 - 365.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
M. Y. Hong, J. R. Lupton, J. S. Morris, N. Wang, R. J. Carroll, L. A. Davidson, R. H. Elder, and R. S. Chapkin
Dietary Fish Oil Reduces O6-Methylguanine DNA Adduct Levels in Rat Colon in Part by Increasing Apoptosis during Tumor Initiation
Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 819 - 826.
[Abstract] [Full Text]

Home page
 Toxicol PatholHome page
P. J. O'Connor, F. C.R. Manning, A. T. Gordon, M. A. Billett, D. P. Cooper, R. H. Elder, and G. P. Margison
Thresholds for Genotoxic Carcinogens: DNA Repair: Kinetics and Thresholds
Toxicol Pathol, May 1, 2000; 28(3): 375 - 381.
[Abstract] [PDF]

Home page
 Cancer Res.Home page
M. Esteller, M. Toyota, M. Sanchez-Cespedes, G. Capella, M. A. Peinado, D. N. Watkins, J.-P. J. Issa, D. Sidransky, S. B. Baylin, and J. G. Herman
Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation Is Associated with G to A Mutations in K-ras in Colorectal Tumorigenesis
Cancer Res., May 1, 2000; 60(9): 2368 - 2371.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
R. K. Wali, S. Skarosi, J. Hart, Y. Zhang, M.e. Dolan, R. C. Moschel, L. Nguyen, R. Mustafi, T. A. Brasitus, and M. Bissonnette
Inhibition of O6-methylguanine-DNA methyltransferase increases azoxymethane-induced colonic tumors in rats
Carcinogenesis, December 1, 1999; 20(12): 2355 - 2360.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Eileen Dolan, B. L. McRae, E. Ferries-Rowe, M. Belanich, G. A. van Seventer, J. Guitart, D. Pezen, T. M. Kuzel, and D. B. Yarosh
O6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents
Clin. Cancer Res., August 1, 1999; 5(8): 2059 - 2064.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
P. N. S. O’Donnell, P. V. Barber, G. P. Margison, and A. C. Povey
Association between O6-Alkylguanine-DNA-alkyltransferase Activity in Peripheral Blood Lymphocytes and Bronchial Epithelial Cells
Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 641 - 645.
[Abstract] [Full Text]

Home page
 CarcinogenesisHome page
P. E. Jackson, D. P. Cooper, P. J. O'Connor, and A. C. Povey
The relationship between 1,2-dimethylhydrazine dose and the induction of colon tumours: tumour development in female SWR mice does not require a K-ras mutational event
Carcinogenesis, March 1, 1999; 20(3): 509 - 513.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.